Introduction Clostridium perfringens type A is a spore-forming Gram-positive anaerobic bacterium that causes gas gangrene in both humans and animals (Songer, 1996; Petit et al., 1999). The disease is a life-threatening necrotizing soft tissue infection that leads to myonecrosis, shock, multiple organ failure, and death of patients (Bryant, 2003; Titball, 2005). C. perfringens sepsis often develops extremely rapidly, accompanied by intravascular hemolysis and metabolic acidosis and has a high mortality rate (Hifumi, 2020). The only current therapeutic measures are hyperbaric oxygen therapy and use of antibiotics, but these treatments are not sufficient to prevent disease progression in some patients (Stephens, 1996; Bryant and Stevens, 2010). More effective therapeutic strategies are urgently required. C. perfringens type A has been reported to produce multiple virulence factors. Many studies have focused on the biological and biochemical activities of α -toxin (or ...